Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-745bb68f8f-lrblm Total loading time: 0 Render date: 2025-01-11T06:15:18.189Z Has data issue: false hasContentIssue false

Chapter 20 - Autoimmune hepatitis

from Section III - Hepatitis and immune disorders

Published online by Cambridge University Press:  05 March 2014

By
Nanda Kerkar  and
Cara L. Mack
Edited by
Frederick J. Suchy ,
Ronald J. Sokol  and
William F. Balistreri
Nanda Kerkar
Affiliation:
Division of Gastroenterology, Hepatology and Nutrition, Pediatric Liver Disease/Liver Transplant Program, Mount Sinai School of Medicine, New York, NY, USA
Cara L. Mack
Affiliation:
Section of Pediatric Gastroenterology, Hepatology and Nutrition, Digestive Health Institute, Children’s Hospital Colorado, University of Colorado School of Medicine, Aurora, CO, USA
Frederick J. Suchy
Affiliation:
University of Colorado Medical Center
Ronald J. Sokol
Affiliation:
University of Colorado Medical Center
William F. Balistreri
Affiliation:
University of Cincinnati College of Medicine
Get access

Summary

Introduction

Autoimmune hepatitis (AIH) is a progressive inflammatory disorder of unknown etiology, characterized histologically by interface hepatitis, serologically by the presence of non-organ specific autoantibodies, biochemically by elevated aminotransferases and serum IgG, and clinically by response to immunosuppressive treatment in the absence of other known causes of liver disease [1].

The spectrum of chronic inflammatory diseases of the liver extends from acute hepatitis to chronic hepatitis and finally to cirrhosis. In 1950, Waldenstrom described a form of chronic hepatitis occurring predominantly in young women with arthralgias, myalgia, hepatosplenomegaly, amenorrhea, skin rashes, fluctuating course, and invariably fatal outcome [2]. The term “lupoid” hepatitis was coined after the detection of anti-nuclear antibodies (ANAs), the then positive test for lupus erythematosus in some of these individuals. The identification of anti-smooth muscle antibody (ASMA) in 1966 led to the nomenclature of “autoimmune chronic active hepatitis” for the first time, in order to distinguish it from systemic lupus erythematosus [3]. The discovery of hepatitis A and B viruses allowed hepatitis caused by these viruses to be excluded. Histologically, the term “chronic persistent hepatitis” was used when the mononuclear inflammation was limited to the portal tracts, while the term “chronic active hepatitis” was used to characterize infiltration of the adjacent hepatic parenchyma (piecemeal necrosis) [4]. Widespread acceptance of the autoimmune basis of this condition was accepted only after controlled trials demonstrated response to immunosuppression and a link with human leukocyte antigens (HLA) HLA-B8 and HLA-DR3 was established. The discovery of hepatitis C virus in 1989 led a panel of international experts, the International Autoimmune Hepatitis Group (IAIHG), to formulate several recommendations regarding the diagnosis and classification of AIH. The IAIHG developed a scoring system to weigh each clinical, laboratory, and histological finding at presentation as well as the response to corticosteroid therapy [5].

Type
Chapter
Information
Liver Disease in Children , pp. 311 - 321
Publisher: Cambridge University Press
Print publication year: 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Mieli-Vergani, G, Vergani, D. Autoimmune hepatitis. Nat Rev 2011;8:320–329.Google ScholarPubMed
Waldenstrom, J, Blueprotein., Nahrungseiweiss. Dtsch Verdau Stoffwechselkr 1950:113–119.Google Scholar
Whittingham, S, Irwin, J, Mackay, IR, Smalley, M. Smooth muscle autoantibody in “autoimmune” hepatitis. Gastroenterology 1966;51:499–505.Google ScholarPubMed
De Groote, J, Desmet, VJ, Gedigk, P, et al. A classification of chronic hepatitis. Lancet 1968;ii:626–628.CrossRefGoogle Scholar
Johnson, PJ, McFarlane, IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993;18:998–1005.CrossRefGoogle ScholarPubMed
Manns, MP, Vogel, A. Autoimmune hepatitis, from mechanisms to therapy. Hepatology 2006;43(Suppl 1):S132–S144.CrossRefGoogle Scholar
Beland, K, Lapierre, P, Alvarez, F. Influence of genes, sex, age and environment on the onset of autoimmune hepatitis. World J Gastroenterol 2009;15:1025–1034.CrossRefGoogle ScholarPubMed
Krawitt, EL. Autoimmune hepatitis. N Engl J Med 2006;354:54–66.CrossRefGoogle ScholarPubMed
Longhi, MS, Ma, Y, Mieli-Vergani, G, Vergani, D. Aetiopathogenesis of autoimmune hepatitis. J Autoimmun 2010;34:7–14.CrossRefGoogle ScholarPubMed
Oo, YH, Hubscher, SG, Adams, DH. Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management. Hepatol Int 2010;4:475–493.CrossRefGoogle Scholar
Ichiki, Y, Aoki, CA, Bowlus, CL, et al. T cell immunity in autoimmune hepatitis. Autoimmun Rev 2005;4:315–321.CrossRefGoogle ScholarPubMed
Longhi, MS, Ma, Y, Mitry, RR, et al. Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun 2005;25:63–71.CrossRefGoogle ScholarPubMed
Mieli-Vergani, G, Vergani, D. Autoimmune hepatitis in children: what is different from adult AIH? Semin Liver Dis 2009;29:297–306.CrossRefGoogle ScholarPubMed
Invernizzi, P, Lleo, A, Podda, M. Interpreting serological tests in diagnosing autoimmune liver diseases. Semin Liver Dis 2007;27:161–172.CrossRefGoogle ScholarPubMed
Czaja, AJ. Autoantibodies as prognostic markers in autoimmune liver disease. Dig Dis Sci 2010;55:2144–2161.CrossRefGoogle ScholarPubMed
Donaldson, PT. Genetics in autoimmune hepatitis. Semin Liver Dis 2002;22:353–364.CrossRefGoogle ScholarPubMed
Vergani, D, Mieli-Vergani, G. Aetiopathogenesis of autoimmune hepatitis. World J Gastroenterol 2008;14:3306–3312.CrossRefGoogle ScholarPubMed
Jaeckel, E, Hardtke-Wolenski, M, Fischer, K. The benefit of animal models for autoimmune hepatitis. Best Pract Res Clin Gastroenterol 2011;25:643–651.CrossRefGoogle ScholarPubMed
Lapierre, P, Djilali-Saiah, I, Vitozzi, S, Alvarez, F. A murine model of type 2 autoimmune hepatitis: xenoimmunization with human antigens. Hepatology 2004;39:1066–1074.CrossRefGoogle ScholarPubMed
Christen, U, Holdener, M, Hintermann, E. Animal models for autoimmune hepatitis. Autoimmun Rev 2007;6:306–311.CrossRefGoogle ScholarPubMed
Manns, MP, Czaja, AJ, Gorham, JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010;51:2193–2213.CrossRefGoogle ScholarPubMed
Hennes, EM, Zeniya, M, Czaja, AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48:169–176.CrossRefGoogle Scholar
Alvarez, F, Berg, PA, Bianchi, FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929–938.CrossRefGoogle ScholarPubMed
Gregorio, GV, Portmann, B, Karani, J, et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 2001;33:544–553.CrossRefGoogle ScholarPubMed
Ebbeson, RL, Schreiber, RA. Diagnosing autoimmune hepatitis in children: is the International Autoimmune Hepatitis Group scoring system useful? Clin Gastroenterol Hepatol 2004;2:935–940.CrossRefGoogle ScholarPubMed
Kerkar, N. Evaluating the AIH scoring system. J Pediatr Gastroenterol Nutr 2005;41:137–138.CrossRefGoogle ScholarPubMed
Kerkar, N, Miloh, T. Sclerosing cholangitis: pediatric perspective. Curr Gastroenterol Rep 2010;12:195–202.CrossRefGoogle ScholarPubMed
Czaja, AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci 2011;56:958–976.CrossRefGoogle ScholarPubMed
Mathis, D, Benoist, C. Aire. Annu Rev Immunol 2009;27:287–312.CrossRefGoogle ScholarPubMed
Davies, EG, Thrasher, AJ. Update on the hyper immunoglobulin M syndromes. Br J Haematol 2010;149:167–180.CrossRefGoogle ScholarPubMed
Cook, GC, Mulligan, R, Sherlock, S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med 1971;40(158):159–185.CrossRefGoogle ScholarPubMed
Rumbo, C, Emerick, KM, Emre, S, Shneider, BL. Azathioprine metabolite measurements in the treatment of autoimmune hepatitis in pediatric patients: a preliminary report. J Pediatr Gastroenterol Nutr 2002;35:391–398.CrossRefGoogle ScholarPubMed
Dunkin, D, Kerkar, N, Arnon, R, Suchy, F, Miloh, T. Allopurinol salvage therapy in pediatric overlap autoimmune hepatitis-primary sclerosing cholangitis with 6-MMP toxicity. J Pediatr Gastroenterol Nutr 2010;51:524–526.CrossRefGoogle ScholarPubMed
Pratt, DS, Flavin, DP, Kaplan, MM. The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine. Gastroenterology 1996;110:271–274.CrossRefGoogle ScholarPubMed
Gregorio, GV, McFarlane, B, Bracken, P, Vergani, D, Mieli-Vergani, G. Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease. Autoimmunity 2002;35:515–519.CrossRefGoogle ScholarPubMed
Kerkar, N, Annunziato, RA, Foley, L, et al. Prospective analysis of nonadherence in autoimmune hepatitis: a common problem. J Pediatr Gastroenterol Nutr 2006;43:629–634.CrossRefGoogle ScholarPubMed
Gregorio, GV, Portmann, B, Reid, F, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997;25:541–547.CrossRefGoogle ScholarPubMed
Czaja, AJ, Manns, MP. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology 2010;139:58–72 e4.CrossRefGoogle ScholarPubMed
Manns, MP, Woynarowski, M, Kreisel, W, et al. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. Gastroenterology 2010;139:1198–1206.CrossRefGoogle Scholar
Lohse, AW, Gil, H. Reactivation of autoimmune hepatitis during budesonide monotherapy, and response to standard treatment. J Hepatol 2011;54:837–839.CrossRefGoogle ScholarPubMed
Czaja, AJ, Carpenter, HA. Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease. J Clin Gastroenterol 2005;39:819–825.CrossRefGoogle ScholarPubMed
Richardson, PD, James, PD, Ryder, SD. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine. J Hepatol 2000;33:371–375.CrossRefGoogle ScholarPubMed
Aw, MM, Dhawan, A, Samyn, M, Bargiota, A, Mieli-Vergani, G. Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up. J Hepatol 2009;51:156–160.CrossRefGoogle ScholarPubMed
Sherman, KE, Narkewicz, M, Pinto, PC. Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitis. J Hepatol 1994;21:1040–1047.CrossRefGoogle ScholarPubMed
Hyams, JS, Ballow, M, Leichtner, AM. Cyclosporine treatment of autoimmune chronic active hepatitis. Gastroenterology 1987;93:890–893.CrossRefGoogle ScholarPubMed
Alvarez, F, Ciocca, M, Canero-Velasco, C, et al. Short-term cyclosporine induces a remission of autoimmune hepatitis in children. J Hepatol 1999;30:222–227.CrossRefGoogle ScholarPubMed
Van Thiel, DH, Wright, H, Carroll, P, et al. Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial. Am J Gastroenterol 1995;90:771–776.Google ScholarPubMed
Miloh, T, Arnon, R, Shneider, B, Suchy, F, Kerkar, N. A retrospective single-center review of primary sclerosing cholangitis in children. Clin Gastroenterol Hepatol 2009;7:239–245.CrossRefGoogle ScholarPubMed
Cuarterolo, ML, Ciocca, ME, Lopez, SI, de Davila, MT, Alvarez, F. Immunosuppressive therapy allows recovery from liver failure in children with autoimmune hepatitis. Clin Gastroenterol Hepatol 2011;9:145–149.CrossRefGoogle ScholarPubMed
Ichai, P, Duclos-Vallee, JC, Guettier, C, et al. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transplant 2007;13:996–1003.CrossRefGoogle ScholarPubMed
Greene, MT, Whitington, PF. Outcomes in pediatric autoimmune hepatitis. Curr Gastroenterol Rep 2009;11:248–251.CrossRefGoogle ScholarPubMed
Montano-Loza, AJ, Carpenter, HA, Czaja, AJ. Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse. Am J Gastroenterol 2007;102:1005–1012.CrossRefGoogle Scholar
Al-Chalabi, T, Underhill, JA, Portmann, BC, McFarlane, IG, Heneghan, MA. Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis. J Hepatol 2008;48:140–147.CrossRefGoogle ScholarPubMed
Radhakrishnan, KR, Alkhouri, N, Worley, S, et al. Autoimmune hepatitis in children: impact of cirrhosis at presentation on natural history and long-term outcome. Dig Liver Dis 2010;42:724–728.CrossRefGoogle ScholarPubMed
Yeoman, AD, Al-Chalabi, T, Karani, JB, et al. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening. Hepatology 2008;48:863–870.CrossRefGoogle ScholarPubMed
Kerkar, N, Hadzic, N, Davies, ET, et al. De-novo autoimmune hepatitis after liver transplantation. Lancet 1998;351:409–413.CrossRefGoogle ScholarPubMed
Kerkar, N, Dugan, C, Rumbo, C, et al. Rapamycin successfully treats post-transplant autoimmune hepatitis. Am J Transplant 2005;5:1085–1089.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Autoimmune hepatitis
    • By Nanda Kerkar, Division of Gastroenterology, Hepatology and Nutrition, Pediatric Liver Disease/Liver Transplant Program, Mount Sinai School of Medicine, New York, NY, USA, Cara L. Mack, Section of Pediatric Gastroenterology, Hepatology and Nutrition, Digestive Health Institute, Children’s Hospital Colorado, University of Colorado School of Medicine, Aurora, CO, USA
  • Edited by Frederick J. Suchy, University of Colorado Medical Center, Ronald J. Sokol, University of Colorado Medical Center, William F. Balistreri
  • Book: Liver Disease in Children
  • Online publication: 05 March 2014
  • Chapter DOI: https://doi.org/10.1017/CBO9781139012102.021
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Autoimmune hepatitis
    • By Nanda Kerkar, Division of Gastroenterology, Hepatology and Nutrition, Pediatric Liver Disease/Liver Transplant Program, Mount Sinai School of Medicine, New York, NY, USA, Cara L. Mack, Section of Pediatric Gastroenterology, Hepatology and Nutrition, Digestive Health Institute, Children’s Hospital Colorado, University of Colorado School of Medicine, Aurora, CO, USA
  • Edited by Frederick J. Suchy, University of Colorado Medical Center, Ronald J. Sokol, University of Colorado Medical Center, William F. Balistreri
  • Book: Liver Disease in Children
  • Online publication: 05 March 2014
  • Chapter DOI: https://doi.org/10.1017/CBO9781139012102.021
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Autoimmune hepatitis
    • By Nanda Kerkar, Division of Gastroenterology, Hepatology and Nutrition, Pediatric Liver Disease/Liver Transplant Program, Mount Sinai School of Medicine, New York, NY, USA, Cara L. Mack, Section of Pediatric Gastroenterology, Hepatology and Nutrition, Digestive Health Institute, Children’s Hospital Colorado, University of Colorado School of Medicine, Aurora, CO, USA
  • Edited by Frederick J. Suchy, University of Colorado Medical Center, Ronald J. Sokol, University of Colorado Medical Center, William F. Balistreri
  • Book: Liver Disease in Children
  • Online publication: 05 March 2014
  • Chapter DOI: https://doi.org/10.1017/CBO9781139012102.021
Available formats
×